BLISS GVS PHARMA LTD. - Intimation Regarding The Appointment Of Additional Non-Executive Independent Director

Download	< Back
22 Jun 2024
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that, subject to approval of shareholders in ensuing 39th Annual General Meeting and based on recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company through circular resolution approved on June 22, 2024 have appointed Dr. Nandkumar Kashinath Chodankar (DIN:02736718) as a Additional Director in the category of Non-Executive Independent Director of the Company for a period of 5 yrs w.e.f. June 22, 2024. Please find enclosed the intimation is this regard.
View all announcements for BLISS GVS PHARMA LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us